# Study of Nasonex® in Improving Sleep Disturbances Related to Perennial Allergic Rhinitis (Study P04909)(TERMINATED)

> **NCT00491374** · PHASE4 · TERMINATED · sponsor: **Schering-Plough**

## Conditions studied

- Perennial Allergic Rhinitis

## Interventions

- **DRUG:** Mometasone Furoate Nasal Spray
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00491374
- **Lead sponsor:** Schering-Plough
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2006-09
- **Primary completion:** —
- **Final completion:** 2007-10
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Very poor enrollment
- **Last updated:** 2009-01-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00491374

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00491374, "Study of Nasonex® in Improving Sleep Disturbances Related to Perennial Allergic Rhinitis (Study P04909)(TERMINATED)". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT00491374. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*